MARIO
DELGADO MORA
Investigador hasta 2008
MARÍA DEL CARMEN
MARTÍNEZ MORA
Profesora titular de universidad
Publicaciones en las que colabora con MARÍA DEL CARMEN MARTÍNEZ MORA (33)
2003
-
PACAP in immunity and inflammation
Annals of the New York Academy of Sciences
-
Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease
Gastroenterology, Vol. 124, Núm. 4, pp. 961-971
2002
-
Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor
Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Núm. 2, pp. 1053-1058
-
Pituitary adenylate-cyclase-activating polypeptide expression in the immune system
NeuroImmunoModulation, Vol. 10, Núm. 3, pp. 177-186
-
Vasoactive intestinal peptide in the immune system: Potential therapeutic role in inflammatory and autoimmune diseases
Journal of Molecular Medicine, Vol. 80, Núm. 1, pp. 16-24
2001
-
Immunology of VIP: A review and therapeutical perspectives
Current Pharmaceutical Design, Vol. 7, Núm. 2, pp. 89-111
-
Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: An experimental immunomodulatory therapy
Journal of Immunology, Vol. 167, Núm. 6, pp. 3182-3189
-
Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease
Nature Medicine, Vol. 7, Núm. 5, pp. 563-568
-
Vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide and immune system: From basic research to potential clinical application
Biomedical Reviews, Vol. 12, Núm. 1, pp. 1-9
2000
-
Anti-inflammatory actions of VIP/PACAP: Role in endotoxemia
Annals of the New York Academy of Sciences
-
Anti-inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: Role in lethal endotoxic shock
European Journal of Immunology, Vol. 30, Núm. 11, pp. 3236-3246
-
Immunobiology of vasoactive intestinal peptide (VIP)
Immunology Today
-
Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP
Annals of the New York Academy of Sciences, Vol. 921, pp. 92-102
1999
-
Regulation of VIP production and secretion by murine lymphocytes
Journal of Neuroimmunology, Vol. 93, Núm. 1-2, pp. 126-138
-
Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide
Journal of Neuroimmunology, Vol. 99, Núm. 1, pp. 61-71
-
VIP and PACAP38 modulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines
Annals of the New York Academy of Sciences
-
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase- activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6
Journal of Immunology, Vol. 162, Núm. 2, pp. 1200-1205
-
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: In vitro and in vivo studies
Journal of Immunology, Vol. 162, Núm. 4, pp. 2358-2367
-
Vasoactive intestinal peptide in thymus: Synthesis, receptors and biological actions
NeuroImmunoModulation, Vol. 6, Núm. 1-2, pp. 97-107
1998
-
VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: In vitro and in vivo studies
Journal of Neuroimmunology, Vol. 85, Núm. 2, pp. 155-167